# Evaluating PN 400 (VIMOVO) in Reducing Gastric Ulcers Compared to Non-steroidal Antiinflammatory Drug (NSAID) Naproxen

> **NCT01129011** · PHASE3 · COMPLETED · sponsor: **POZEN** · enrollment: 420 (actual)

## Conditions studied

- Gastric Ulcer

## Interventions

- **DRUG:** PN400 (VIMOVO)
- **DRUG:** Naproxen

## Key facts

- **NCT ID:** NCT01129011
- **Lead sponsor:** POZEN
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-09
- **Primary completion:** 2008-09
- **Final completion:** 2008-10
- **Target enrollment:** 420 (ACTUAL)
- **Last updated:** 2010-12-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01129011

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01129011, "Evaluating PN 400 (VIMOVO) in Reducing Gastric Ulcers Compared to Non-steroidal Antiinflammatory Drug (NSAID) Naproxen". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01129011. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*